>If we do better than the ALNY deal, that will amazing...The deal ALNY just cut, has to be the best deal I've ever seen.<
That’s quite right—there has never been a biotech deal based on technology alone with economics like the one ALNY just struck. If GTC can accomplish something even half as impressive as what ALNY just did, shareholders will do very well indeed.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”